Gynaecological tumours: new developments in imaging and treatment – recommendations for clinical practice and directions for the future

by Vladimir Zajonc | April 18, 2023

MD 14-1 2 min Chairperson’s introduction Andrea Grace Rockall, Godalming / UK Learning Objectives 1. To highlight new developments in the treatment of gynaecological tumours. 2. To critically review recent evidence in imaging and put this in perspective of new...

Breast cancer screening: the updated EU council recommendations and its impact on clinical practice

by Vladimir Zajonc | April 18, 2023

MD 13-1 2 min Chairperson’s introduction Michael Fuchsjäger, Graz / Austria Learning Objectives 1. To review the updated EU council recommendations on breast cancer screening. 2. To highlight the evidence for MRI of dense breasts. 3. To share its impact on...

Prostate cancer screening and early detection: the updated EU council recommendations and its impact on clinical practice

by Vladimir Zajonc | April 18, 2023

MD 12-1 2 min Chairperson’s introduction Heinz-Peter Schlemmer, Heidelberg / Germany Learning Objectives 1. To highlight new developments in the treatment of early-stage prostate cancer. 2. To review recent screening recommendations and review the evidence. 3....

Chronic pancreatitis: new developments in imaging and treatment – recommendations for clinical practice and directions for the future

by Vladimir Zajonc | April 18, 2023

MD 11-1 2 min Chairperson’s introduction Riccardo Manfredi, Rome / Italy Learning Objectives 1. To highlight new developments in the treatment of pancreatitis. 2. To critically review recent developments in imaging and put this in perspective of the treatment...

Non-alcoholic fatty liver disease: new developments in imaging and treatment – recommendations for clinical practice and directions for the future

by Vladimir Zajonc | April 18, 2023

MD 10-1 2 min Chairperson’s introduction Olivier Lucidarme, Paris / France Learning Objectives 1. To highlight new developments in treating non-alcoholic fatty liver disease and NASH. 2. To critically review recent evidence in imaging and put this in perspective...
« Older Entries
Next Entries »

Recent Posts

  • ECR 2026 Announcement
  • PEP After ECR
  • OCEAN-SAFE IMAGING: REDUCING RADIOLOGY’S IMPACT
  • HEALTHY PEOPLE HEALTHY PLANET: THE POWER OF THE CLOUD IN RADIOLOGY
  • AROUND THE WORLD WITH SIMON REEVE

Recent Comments

  • Tauseef Ahmad Wani on Artificial intelligence (AI) for health imaging: transforming cancer diagnosis and analysis with advanced image repositories
  • Simona Bartovicova on Imaging of focal renal lesions
  • Peiman Masoumi on Imaging of focal renal lesions
  • AKRAM Abdo Alzamzami on Radiologists and radiographers: communicating with patients
  • Mohammed Mohammed Beshr on The right patient, at the right time: How to optimize outcomes for HCC patients with liver imaging?

Archives

  • November 2025
  • March 2025
  • February 2025
  • January 2025
  • February 2024
  • February 2023
  • July 2022
  • June 2022
  • March 2022
  • February 2022

Categories

  • a ECR 2022 Industry Blog
  • Agfa
  • Agfa HealthCare
  • Aidence
  • App Adverts
  • Bayer
  • Certificates
  • CME ECR App
  • Content
  • deepc GmbH
  • ECR 2020 Programme
  • ECR 2020 Technical Issues
  • ECR 2020 Virtual Exhibition
  • ECR 2021 CME Accreditation
  • ECR 2021 Confirmations
  • ECR 2021 Interactivity & Networking
  • ECR 2021 Login
  • ECR 2021 On-Demand Access
  • ECR 2021 Technical Issues
  • ESR Premium Education Package
  • GE Healthcare
  • General Information
  • Guerbet
  • IBEX
  • Login
  • Membership & Pricing
  • Payment & Invoices
  • Technical Problems
  • What's going on today

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
ESR

European Society of Radiology
Am Gestade 1
1010 Vienna, Austria
[email protected]
Phone: +43 1 53340640

  • Legal Disclaimer
  • Cookie Policy
  • ESR Premium Education Package
  • Data Protection Information
  • Terms & Conditions
  • FAQ
Copyright © 2025 European Society of Radiology
Login to ePortal